nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1D—meninx—peripheral nervous system neoplasm	0.189	0.198	CbGeAlD
Xylometazoline—HTR1B—dura mater—peripheral nervous system neoplasm	0.18	0.188	CbGeAlD
Xylometazoline—HTR1D—dura mater—peripheral nervous system neoplasm	0.174	0.182	CbGeAlD
Xylometazoline—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0774	0.0808	CbGeAlD
Xylometazoline—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.0749	0.0782	CbGeAlD
Xylometazoline—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.0551	0.0576	CbGeAlD
Xylometazoline—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.0534	0.0557	CbGeAlD
Xylometazoline—HTR1B—ganglion—peripheral nervous system neoplasm	0.0279	0.0291	CbGeAlD
Xylometazoline—HTR1D—ganglion—peripheral nervous system neoplasm	0.027	0.0282	CbGeAlD
Xylometazoline—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.0137	0.0143	CbGeAlD
Xylometazoline—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.0133	0.0139	CbGeAlD
Xylometazoline—HTR1B—brainstem—peripheral nervous system neoplasm	0.0121	0.0127	CbGeAlD
Xylometazoline—HTR1D—brainstem—peripheral nervous system neoplasm	0.0117	0.0123	CbGeAlD
Xylometazoline—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00972	0.0101	CbGeAlD
Xylometazoline—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.00916	0.00957	CbGeAlD
Xylometazoline—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00902	0.00942	CbGeAlD
Xylometazoline—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00775	0.00809	CbGeAlD
Xylometazoline—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.00445	0.00464	CbGeAlD
Xylometazoline—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.00424	0.00443	CbGeAlD
Xylometazoline—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.00338	0.00353	CbGeAlD
Xylometazoline—HTR1D—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.91e-05	0.00188	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—GNAS—peripheral nervous system neoplasm	7.9e-05	0.00187	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	7.82e-05	0.00185	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—NME1—peripheral nervous system neoplasm	7.82e-05	0.00185	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	7.76e-05	0.00184	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.75e-05	0.00184	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.75e-05	0.00184	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.72e-05	0.00183	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.64e-05	0.00181	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—HGF—peripheral nervous system neoplasm	7.53e-05	0.00178	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—COX2—peripheral nervous system neoplasm	7.52e-05	0.00178	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—KNG1—peripheral nervous system neoplasm	7.34e-05	0.00174	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.3e-05	0.00173	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.18e-05	0.0017	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.18e-05	0.0017	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.16e-05	0.0017	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.1e-05	0.00168	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.05e-05	0.00167	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.03e-05	0.00167	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.01e-05	0.00166	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	7e-05	0.00166	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.92e-05	0.00164	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.82e-05	0.00162	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.77e-05	0.00161	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.77e-05	0.0016	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.71e-05	0.00159	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GNS—peripheral nervous system neoplasm	6.62e-05	0.00157	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.61e-05	0.00157	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.56e-05	0.00155	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.54e-05	0.00155	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.47e-05	0.00153	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.44e-05	0.00153	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.43e-05	0.00152	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	6.42e-05	0.00152	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	6.35e-05	0.0015	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.28e-05	0.00149	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.15e-05	0.00146	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.15e-05	0.00146	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.13e-05	0.00145	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	6.11e-05	0.00145	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.11e-05	0.00145	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	6.11e-05	0.00145	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.96e-05	0.00141	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.92e-05	0.0014	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—PTPN11—peripheral nervous system neoplasm	5.88e-05	0.00139	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	5.72e-05	0.00136	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.71e-05	0.00135	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.71e-05	0.00135	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	5.68e-05	0.00135	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.65e-05	0.00134	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.62e-05	0.00133	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.55e-05	0.00132	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.54e-05	0.00131	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.53e-05	0.00131	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—PTPN11—peripheral nervous system neoplasm	5.49e-05	0.0013	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.38e-05	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.34e-05	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.31e-05	0.00126	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.18e-05	0.00123	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.17e-05	0.00122	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.1e-05	0.00121	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.1e-05	0.00121	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.08e-05	0.00121	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.99e-05	0.00118	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.99e-05	0.00118	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.96e-05	0.00118	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ENO2—peripheral nervous system neoplasm	4.94e-05	0.00117	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.91e-05	0.00116	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.86e-05	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.85e-05	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.77e-05	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.71e-05	0.00112	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.69e-05	0.00111	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.64e-05	0.0011	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.53e-05	0.00107	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.53e-05	0.00107	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.52e-05	0.00107	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.46e-05	0.00106	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.46e-05	0.00106	CbGpPWpGaD
Xylometazoline—ADRA2B—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	4.43e-05	0.00105	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.37e-05	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.36e-05	0.00103	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.27e-05	0.00101	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.25e-05	0.00101	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.24e-05	0.00101	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.21e-05	0.000998	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.2e-05	0.000995	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.19e-05	0.000992	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—BCHE—peripheral nervous system neoplasm	4.17e-05	0.000989	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.17e-05	0.000988	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.16e-05	0.000985	CbGpPWpGaD
Xylometazoline—ADRA2C—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	4.14e-05	0.000981	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.06e-05	0.000961	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.04e-05	0.000959	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	4.01e-05	0.000951	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.98e-05	0.000944	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.96e-05	0.000939	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.96e-05	0.000939	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—TH—peripheral nervous system neoplasm	3.92e-05	0.00093	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.87e-05	0.000918	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.83e-05	0.000909	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.74e-05	0.000886	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.71e-05	0.00088	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.68e-05	0.000873	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.63e-05	0.000861	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.63e-05	0.000861	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.58e-05	0.000849	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	3.53e-05	0.000838	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.52e-05	0.000835	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.46e-05	0.00082	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	3.39e-05	0.000803	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.37e-05	0.0008	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.36e-05	0.000796	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—NRAS—peripheral nervous system neoplasm	3.3e-05	0.000782	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.28e-05	0.000777	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.23e-05	0.000766	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GNAS—peripheral nervous system neoplasm	3.2e-05	0.000759	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	3.19e-05	0.000755	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.18e-05	0.000753	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.15e-05	0.000747	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	3.14e-05	0.000745	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.13e-05	0.000742	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.12e-05	0.000741	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.1e-05	0.000735	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.06e-05	0.000726	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.01e-05	0.000715	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.92e-05	0.000692	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.91e-05	0.000689	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.87e-05	0.000681	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.87e-05	0.00068	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.75e-05	0.000653	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	2.7e-05	0.000641	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	2.68e-05	0.000636	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.68e-05	0.000635	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.68e-05	0.000635	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.64e-05	0.000625	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.62e-05	0.000622	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	2.6e-05	0.000617	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	2.59e-05	0.000613	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.58e-05	0.000611	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.57e-05	0.000609	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.56e-05	0.000607	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	2.55e-05	0.000605	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.55e-05	0.000605	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	2.53e-05	0.000599	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.52e-05	0.000599	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.49e-05	0.00059	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	2.41e-05	0.000572	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.37e-05	0.000562	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.34e-05	0.000555	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	2.28e-05	0.000541	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.25e-05	0.000532	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.21e-05	0.000523	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.18e-05	0.000516	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	2.13e-05	0.000505	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	2.05e-05	0.000486	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.04e-05	0.000483	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.03e-05	0.000481	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2e-05	0.000473	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.99e-05	0.000472	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.96e-05	0.000465	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.92e-05	0.000455	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.89e-05	0.000449	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.88e-05	0.000446	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.87e-05	0.000443	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.86e-05	0.000442	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.86e-05	0.000441	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.85e-05	0.000438	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.83e-05	0.000434	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.83e-05	0.000433	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.81e-05	0.000429	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.74e-05	0.000413	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.73e-05	0.000411	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.7e-05	0.000402	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.66e-05	0.000394	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.66e-05	0.000393	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.64e-05	0.00039	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.63e-05	0.000386	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.6e-05	0.000379	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.58e-05	0.000375	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.57e-05	0.000373	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.55e-05	0.000368	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.54e-05	0.000365	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.52e-05	0.00036	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.51e-05	0.000358	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.48e-05	0.000352	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.47e-05	0.000349	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.45e-05	0.000344	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.45e-05	0.000343	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.44e-05	0.000342	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.44e-05	0.000342	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.43e-05	0.000339	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.41e-05	0.000335	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.39e-05	0.000329	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.36e-05	0.000323	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.35e-05	0.000319	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.34e-05	0.000316	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.33e-05	0.000315	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.33e-05	0.000314	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.31e-05	0.000311	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.31e-05	0.000311	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.29e-05	0.000305	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.24e-05	0.000293	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.22e-05	0.00029	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.21e-05	0.000287	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000285	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.2e-05	0.000284	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.19e-05	0.000283	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.19e-05	0.000281	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.18e-05	0.000279	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.17e-05	0.000277	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.16e-05	0.000275	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.13e-05	0.000269	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.13e-05	0.000267	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.12e-05	0.000265	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.12e-05	0.000265	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.11e-05	0.000263	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.1e-05	0.000261	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000259	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.08e-05	0.000257	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000254	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.04e-05	0.000247	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.03e-05	0.000243	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.02e-05	0.000241	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1e-05	0.000237	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.94e-06	0.000236	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.81e-06	0.000232	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.78e-06	0.000232	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.71e-06	0.00023	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.16e-06	0.000217	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.11e-06	0.000216	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.09e-06	0.000215	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.76e-06	0.000208	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	8.65e-06	0.000205	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.57e-06	0.000203	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.56e-06	0.000203	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.47e-06	0.000201	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.43e-06	0.0002	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.19e-06	0.000194	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.06e-06	0.000191	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.74e-06	0.000183	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.48e-06	0.000177	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.23e-06	0.000171	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.16e-06	0.00017	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.11e-06	0.000169	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	7.02e-06	0.000166	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.95e-06	0.000165	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.65e-06	0.000158	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.32e-06	0.00015	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.87e-06	0.000139	CbGpPWpGaD
